News
STAT+: Lilly’s Jaypirca approved as first-line CLL therapy
Eli Lilly’s Jaypirca has won FDA approval for previously untreated chronic lymphocytic leukemia and small lymphocytic lymphoma.
More in Health
- Burnham urged to ‘end cycle of harm’ after scale of child-on-child sexual abuse revealed The Guardian — Society
- Republicans and Democrats find a unifying target: Pharmacy benefit managers NPR — Health
- Early Lampard findings could come within weeks BBC News — Health
- Dying Patients Are Inundated by Misinformation. My Dad Was One of Them. The New York Times — Health
- WHO Director-General visits Jordan to recognize strong collaboration on health system delivery, emergency relief and advancing mental health World Health Organization